Collection of Samples USOPTIVAL Study

RecruitingOBSERVATIONAL
Enrollment

1,300

Participants

Timeline

Start Date

December 30, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Colorectal Cancer (CRC)Advanced Adenomas (AA)
Interventions
DIAGNOSTIC_TEST

Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel

Evaluate the performance of a preliminary panel of biomarkers

Trial Locations (16)

12553

RECRUITING

Mid Hudson Medical Research, New Windsor

15401

COMPLETED

Frontier Clinical Research, Uniontown

19104

RECRUITING

University of Pennsylvania, Philadelphia

19111

COMPLETED

Fox Chase Cancer Center, Philadelphia

24014

COMPLETED

Gastroenterology Consultants of SW Virginia, Roanoke

33021

COMPLETED

Center for Gastrointestinal Disorders, Hollywood

33805

RECRUITING

Lakeland Regional Cancer Center, Lakeland

38261

COMPLETED

Clinical Trials Network, Union City

62702

RECRUITING

Springfield Clinic, Springfield

70121

COMPLETED

Ochsner Clinic, New Orleans

77017

COMPLETED

Vilo Research Group, Houston

91910

COMPLETED

Precision Recearch Institute, Chula Vista

92114

COMPLETED

Precision Research Institute, San Diego

92123

COMPLETED

Medical Associates Research Group, San Diego

94598

COMPLETED

Clinical Research of California, Walnut Creek

02215

COMPLETED

Dana Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
lead

Universal Diagnostics

INDUSTRY

NCT04792684 - Collection of Samples USOPTIVAL Study | Biotech Hunter | Biotech Hunter